| Elizabeth Tamar Friedman, | |
|
8132 192nd St, Jamaica, NY 11423-1045 | |
| (516) 967-6813 | |
| Not Available |
| Full Name | Elizabeth Tamar Friedman |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 8132 192nd St, Jamaica, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134905102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 033463 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Tamar Friedman, 8132 192nd St, Jamaica, NY 11423-1045 Ph: (516) 967-6813 | Elizabeth Tamar Friedman, 8132 192nd St, Jamaica, NY 11423-1045 Ph: (516) 967-6813 |
News Archive
The New York Times: "About 4,000 Americans - rather than about 1,200 - have died of swine flu since the disease emerged in April, according to new figures being calculated by [CDC] epidemiologists" - an estimate that combines the number of "deaths from laboratory-confirmed cases of the flu and deaths that appear to be brought on by flu, even though the patient may have ultimately died of bacterial pneumonia, other infections or organ failure."
IBM and Cellomics have announced they have launched a customized information technology (IT) solution that allows biopharmaceutical scientists and academic researchers to better understand how potential drug candidates or targets of interest affect cellular function.
Up to 8 percent of people in the U.S. suffer from post-traumatic stress disorder (PTSD) as the result of witnessing or being the victim of a traumatic event. People with PTSD have been in a situation in which they were at risk of death, serious injury or sexual violence or have seen first-hand loved ones faces such threats. They may experience flashbacks, emotional detachment and jumpiness, among other symptoms that affect their ability to function in everyday life.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and secondary endpoints in patients with moderate-to-severe chronic sinusitis with nasal polyps (CSwNP) who did not respond to intranasal corticosteroids.
› Verified 4 days ago
Tsipora Mishaely, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18635 80th Dr, Jamaica, NY 11432 Phone: 917-244-4161 | |
Richard Muller, MS SLP TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9110 146th St, Jamaica, NY 11435 Phone: 718-468-9000 | |
Laurie Ann Hernandez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8422 Midland Pkwy, Jamaica, NY 11432 Phone: 917-597-6920 | |
Elizabeth Barrett Ryan, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8516 Somerset St, Jamaica, NY 11432 Phone: 917-817-0836 Fax: 718-657-1208 | |
Janine Dominguez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10959 Inwood St, Jamaica, NY 11435 Phone: 718-526-5523 Fax: 718-526-8191 | |
Cassandra Dantzler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12520 Sutphin Blvd, Jamaica, NY 11434 Phone: 718-558-2900 Fax: 718-925-9020 | |
Lena Layne, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17603 Croydon Rd, Jamaica, NY 11432 Phone: 718-526-1364 |